المؤلفون: Schol E, Bosch A van den, Ligthart FATM, Romer JC, Ruijg GJ, Schaeffer GJ, Dinkelman GH, Kok IC, Paauw KFB de, PB-NOP

مصطلحات موضوعية: gemeenten, municipalities, amsterdam, carbon dioxide, klimaatverandering, reduction, reductie, climatic changes, kooldioxide, steden, beleid, cities, policy

وصف الملف: 260 p

URL الوصول: https://explore.openaire.eu/search/publication?articleId=narcis______::9ee23e4e88ceb1547d37d5355ee0699f
http://hdl.handle.net/10029/255624

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: van Sluis J; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. j.van.sluis@umcg.nl., Noordzij W; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Kok IC; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., de Groot DJA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Jalving M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Lub-de Hooge MN; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Brouwers AH; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Boellaard R; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

المصدر: Molecular imaging and biology [Mol Imaging Biol] 2023 Apr; Vol. 25 (2), pp. 435-441. Date of Electronic Publication: 2022 Oct 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 101125610 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-2002 (Electronic) Linking ISSN: 15361632 NLM ISO Abbreviation: Mol Imaging Biol Subsets: MEDLINE

مواضيع طبية MeSH: Positron Emission Tomography Computed Tomography* , Positron-Emission Tomography*/methods, Humans ; Artificial Intelligence ; Tissue Distribution ; Pilot Projects ; Radiometry/methods

المؤلفون: Kok IC; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Hooiveld JS; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., van de Donk PP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Giesen D; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., van der Veen EL; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Lub-de Hooge MN; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Brouwers AH; Department of Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Hiltermann TJN; Department of Pulmonary Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., van der Wekken AJ; Department of Pulmonary Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Hijmering-Kappelle LBM; Department of Pulmonary Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Timens W; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Groen HJM; Department of Pulmonary Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Uyterlinde W; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Hiel B; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands., Haanen JB; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Groot DJA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Jalving M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: e.g.e.de.vries@umcg.nl.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2022 Jan; Vol. 33 (1), pp. 80-88. Date of Electronic Publication: 2021 Nov 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/diagnostic imaging , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/metabolism , Lung Neoplasms*/diagnostic imaging , Lung Neoplasms*/drug therapy , Lung Neoplasms*/metabolism, Antibodies, Monoclonal, Humanized ; Humans ; Positron-Emission Tomography/methods ; Programmed Cell Death 1 Receptor ; Tissue Distribution

المؤلفون: Kist de Ruijter L; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Hooiveld-Noeken JS; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Giesen D; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Lub-de Hooge MN; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kok IC; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Brouwers AH; Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Nguyen MTL; CytomX Therapeutics Inc., South San Francisco, California., Lu H; CytomX Therapeutics Inc., South San Francisco, California., Gietema JA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Jalving M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Groot DJA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Vasiljeva O; CytomX Therapeutics Inc., South San Francisco, California., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Oct 01; Vol. 27 (19), pp. 5325-5333.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/diagnostic imaging , Neoplasms*/drug therapy , Radioisotopes*/therapeutic use, B7-H1 Antigen/metabolism ; Humans ; Positron-Emission Tomography/methods ; Tissue Distribution ; Zirconium

المؤلفون: Hanemaaijer SH; Department of Otorhinolaryngology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., Kok IC; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., Fehrmann RSN; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., van der Vegt B; Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., Gietema JA; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., Plaat BEC; Department of Otorhinolaryngology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., van Vugt MATM; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., Vergeer MR; Department of Radiation Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Leemans CR; Department of Otolaryngology/Head and Neck Surgery, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Langendijk JA; Department of Radiotherapy, University of Groningen University Medical Center Groningen, Groningen, Netherlands., Voortman J; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Buter J; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Oosting SF; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

المصدر: Frontiers in oncology [Front Oncol] 2020 Jun 05; Vol. 10, pp. 761. Date of Electronic Publication: 2020 Jun 05 (Print Publication: 2020).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Moek KL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Waaijer SJH; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kok IC; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Suurs FV; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Brouwers AH; Department of Radiology, Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Menke-van der Houven van Oordt CW; Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands., Wind TT; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Gietema JA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Schröder CP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Mahesh SVK; Department of Radiology, Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Jorritsma-Smit A; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Lub-de Hooge MN; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Fehrmann RSN; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Groot DJA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. e.g.e.de.vries@umcg.nl.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Jun 15; Vol. 25 (12), pp. 3517-3527. Date of Electronic Publication: 2019 Feb 11.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma/*metabolism , Antibodies, Bispecific/*pharmacokinetics , Gastrointestinal Neoplasms/*metabolism , Radioisotopes/*pharmacokinetics , Radiopharmaceuticals/*pharmacokinetics , T-Lymphocytes/*immunology , Zirconium/*pharmacokinetics, Adenocarcinoma/diagnostic imaging ; Adenocarcinoma/drug therapy ; Aged ; Antibodies, Bispecific/administration & dosage ; Antibodies, Bispecific/immunology ; Antibodies, Monoclonal/therapeutic use ; CD3 Complex/immunology ; Carcinoembryonic Antigen/immunology ; Carcinoembryonic Antigen/metabolism ; Female ; GPI-Linked Proteins/metabolism ; Gastrointestinal Neoplasms/diagnostic imaging ; Gastrointestinal Neoplasms/drug therapy ; Humans ; Male ; Middle Aged ; Positron-Emission Tomography/methods ; Radioisotopes/administration & dosage ; Radiopharmaceuticals/administration & dosage ; Radiopharmaceuticals/immunology ; T-Lymphocytes/metabolism ; Tissue Distribution ; Zirconium/administration & dosage

المؤلفون: Bensch F; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., van der Veen EL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Lub-de Hooge MN; Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Jorritsma-Smit A; Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Boellaard R; Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kok IC; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Oosting SF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Schröder CP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Hiltermann TJN; Pulmonary Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., van der Wekken AJ; Pulmonary Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Groen HJM; Pulmonary Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kwee TC; Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Gietema JA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Bohorquez SS; Genentech, San Francisco, CA, USA., de Crespigny A; Genentech, San Francisco, CA, USA., Williams SP; Genentech, San Francisco, CA, USA., Mancao C; Genentech, Basel, Switzerland., Brouwers AH; Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Fine BM; Genentech, San Francisco, CA, USA., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. e.g.e.de.vries@umcg.nl.

المصدر: Nature medicine [Nat Med] 2018 Dec; Vol. 24 (12), pp. 1852-1858. Date of Electronic Publication: 2018 Nov 26.

نوع المنشور: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Positron-Emission Tomography*, Antibodies, Monoclonal/*administration & dosage , B7-H1 Antigen/*administration & dosage , Radioisotopes/*administration & dosage , Zirconium/*administration & dosage, Adult ; Aged ; Antibodies, Monoclonal/chemistry ; Antibodies, Monoclonal, Humanized ; B7-H1 Antigen/chemistry ; Biopsy ; Carcinoma, Non-Small-Cell Lung/diagnostic imaging ; Carcinoma, Non-Small-Cell Lung/pathology ; Cell Line, Tumor ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Radioisotopes/chemistry ; Radiopharmaceuticals/administration & dosage ; Radiopharmaceuticals/chemistry ; Tissue Distribution/drug effects ; Triple Negative Breast Neoplasms/diagnostic imaging ; Triple Negative Breast Neoplasms/pathology ; Urinary Bladder Neoplasms/diagnostic imaging ; Urinary Bladder Neoplasms/pathology ; Zirconium/chemistry

المؤلفون: Waaijer SJH; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Kok IC; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Eisses B; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Schröder CP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Jalving M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Brouwers AH; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; and., Lub-de Hooge MN; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; and.; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands e.g.e.de.vries@umcg.nl.

المصدر: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2018 May; Vol. 59 (5), pp. 726-732. Date of Electronic Publication: 2018 Jan 25.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

مواضيع طبية MeSH: Drug Development* , Molecular Imaging*, Neoplasms/*diagnostic imaging , Neoplasms/*drug therapy, Activin Receptors, Type II/metabolism ; Antibodies, Monoclonal/chemistry ; Antibodies, Monoclonal/pharmacology ; Antineoplastic Agents/chemistry ; Antineoplastic Agents/pharmacology ; Biopsy ; Drug Delivery Systems ; ErbB Receptors/metabolism ; Humans ; Optical Imaging ; Positron-Emission Tomography ; Radioisotopes/chemistry ; Receptors, Growth Factor/metabolism ; Tomography, Emission-Computed, Single-Photon

المؤلفون: Moek KL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Giesen D; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Kok IC; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., de Groot DJA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Jalving M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Fehrmann RSN; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Lub-de Hooge MN; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; and., Brouwers AH; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands e.g.e.de.vries@umcg.nl.

المصدر: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2017 Sep; Vol. 58 (Suppl 2), pp. 83S-90S.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

مواضيع طبية MeSH: Diagnostic Techniques and Procedures*, Immunoconjugates/*therapeutic use, Animals ; Humans ; Immunotherapy ; Isotope Labeling ; Molecular Imaging